MarketCapExport financials
Research Frontiers Incorporated (REFR)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Research Frontiers Incorporated Balance Sheet 2025-2008 | REFR
Brief overview of Research Frontiers Incorporated's balance sheet structure
This overview follows the five latest available annual observations between 2021 and 2025.
Assets declined from $4.5 million to $2.3 million, or -50.5%. The contraction calls for context such as disposals, restructuring or weaker operations.
Liabilities grew faster than assets: +73% versus -50.5%. A substantial part of expansion was externally funded.
Equity finances 41.5% of the balance sheet, compared with 83.2% at the start. The cushion remains adequate.
Net debt to equity stands at 0.54x; the current burden does not look excessive.
Cash represents 29.5% of assets versus 5.9% initially, showing how the immediate liquidity reserve changed.
The balance sheet includes a negative accumulated result of -$127.6 million. It should be assessed alongside historical profits and capital distributions.
Conclusion
Research Frontiers Incorporated's balance sheet profile remains vulnerable. Lower liabilities and capital accumulation are the main routes to improvement.
Annual Balance Sheet Research Frontiers Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
502 K | -698 K | -2.21 M | -3.77 M | 376 K | -3.96 M | -5.62 M | -2.97 M | -1.74 M | -1.69 M | -5.71 M | -7.57 M | -5.87 M | -8.39 M | -2.4 M | - | - | - |
Long Term Debt |
1.02 M | 1.17 M | 55.4 K | 268 K | 464 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
146 K | 130 K | 212 K | 196 K | 182 K | 166 K | 163 K | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | 646 K | 813 K | 501 K | - | - | - | - | - | - | - | - | - | - |
Total Current Liabilities |
298 K | 269 K | 277 K | 302 K | 298 K | 226 K | 387 K | 458 K | 314 K | 369 K | 468 K | 483 K | 162 K | 242 K | 310 K | 312 K | - | - |
Total Liabilities |
1.32 M | 1.44 M | 333 K | 570 K | 762 K | 872 K | 1.2 M | 959 K | 314 K | 369 K | 468 K | 483 K | 162 K | 242 K | 310 K | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | 7.73 K | 50.6 K | 824 | - | - | - | 25 K | 25 K | 25 K | 25 K | - | - |
Retained Earnings |
-128 M | -126 M | -124 M | -122 M | -120 M | -118 M | -115 M | -112 M | -109 M | -107 M | -102 M | -98.1 M | -93.3 M | -87.5 M | -84.4 M | -80.3 M | - | - |
Total Assets |
2.25 M | 4.04 M | 3.85 M | 5.37 M | 4.55 M | 6.2 M | 8.26 M | 4.06 M | 2.88 M | 5.27 M | 9.54 M | 12.6 M | 12 M | 14.4 M | 4.42 M | 7.78 M | - | - |
Cash and Cash Equivalents |
664 K | 1.99 M | 2.48 M | 4.23 M | 270 K | 4.77 M | 6.59 M | 2.97 M | 1.74 M | 1.69 M | 5.71 M | 7.57 M | 5.87 M | 8.39 M | 2.4 M | 6.96 M | 3.76 M | 2.37 M |
Book Value |
934 K | 2.6 M | 3.52 M | 4.8 M | 3.78 M | 5.33 M | 7.06 M | 3.1 M | 2.57 M | 4.9 M | 9.08 M | 12.1 M | 11.9 M | 14.2 M | 4.11 M | 7.78 M | - | - |
Total Shareholders Equity |
934 K | 2.6 M | 3.52 M | 4.8 M | 3.78 M | 5.33 M | 7.06 M | 3.1 M | 2.57 M | 4.9 M | 9.08 M | 12.1 M | 11.9 M | 14.2 M | 4.11 M | 7.47 M | 4.17 M | 4.87 M |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Balance Sheet Research Frontiers Incorporated
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
942 K | 981 K | 1.06 M | 1.09 M | 1.13 M | 1.17 M | - | - | - | 55.4 K | 110 K | 164 K | 217 K | 268 K | 318 K | - | 417 K | 464 K | 511 K | 557 K | 603 K | 646 K | 646 K | 646 K | 646 K | 813 K | 813 K | 813 K | 813 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
1.35 M | 1.3 M | 1.27 M | 1.37 M | 1.34 M | 1.44 M | 176 K | 390 K | - | 333 K | 374 K | 450 K | 501 K | 570 K | 586 K | - | 704 K | 762 K | 787 K | 858 K | 911 K | 872 K | 872 K | 872 K | 872 K | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 959 K | 959 K | 959 K | 959 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
69.1 K | - | 5.34 K | 71.6 K | - | - | - | 125 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 78.9 K | 7.73 K | 71.7 K | 35.9 K | 51.2 K | 50.6 K | 39 K | 103 K | 153 K | 824 | 46.7 K | 824 | 824 | - | 10 K | 20 K | 30.8 K | - | 10 K | 22.7 K | 32.7 K | - | 16.2 K | 22.5 K | 56.2 K | 25 K | 25 K | 25 K | 25 K | 25 K | 25 K | 25 K | 25 K | 25 K | 25 K | 25 K | 25 K |
Retained Earnings |
-129 M | -128 M | -127 M | -127 M | -126 M | -126 M | -125 M | -125 M | - | -124 M | -124 M | -123 M | -123 M | -122 M | -122 M | - | -120 M | -120 M | -119 M | -119 M | -118 M | -118 M | -118 M | -118 M | -118 M | -115 M | -115 M | -115 M | -115 M | -112 M | -112 M | -112 M | -112 M | -109 M | -109 M | -109 M | -109 M | -107 M | -107 M | -107 M | -107 M | -102 M | -102 M | -102 M | -102 M | -98.1 M | -98.1 M | -98.1 M | -98.1 M | -93.7 M | -93.7 M | -93.3 M | -93.3 M | -87.5 M | -87.5 M | -87.5 M | -87.5 M | -84.4 M | -84.4 M | -84.4 M | -84.4 M |
Total Assets |
2.48 M | 3.08 M | 2.77 M | 3.17 M | 3.77 M | 4.04 M | 3 M | 3.38 M | - | 3.85 M | 4.23 M | 4.77 M | 5.32 M | 5.37 M | 5.97 M | - | 3.86 M | 4.55 M | 5.14 M | 5.19 M | 5.77 M | 6.2 M | 6.2 M | 6.2 M | 6.2 M | 8.26 M | 8.26 M | 8.26 M | 8.26 M | 4.06 M | 4.06 M | 4.06 M | 4.06 M | 2.88 M | 2.88 M | 2.88 M | 2.88 M | 5.27 M | 5.27 M | 5.27 M | 5.27 M | 9.54 M | 9.54 M | 9.54 M | 9.54 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 12 M | 12 M | 12 M | 12 M | 14.4 M | 14.4 M | 14.4 M | 14.4 M | 4.42 M | 4.42 M | 4.42 M | 4.42 M |
Cash and Cash Equivalents |
1.09 M | 1.28 M | 1.13 M | 1.27 M | 1.35 M | 1.99 M | 1.65 M | 1.91 M | - | 2.48 M | 525 K | 3.52 M | 1.15 M | 4.23 M | 4.8 M | - | 2.47 M | 270 K | 207 K | 340 K | 4.22 M | 4.77 M | 4.77 M | 4.77 M | 4.77 M | 6.59 M | 6.59 M | 6.59 M | 6.59 M | 2.97 M | 2.97 M | 2.97 M | 2.97 M | 1.74 M | 1.74 M | 1.74 M | 1.74 M | 1.69 M | 1.69 M | 1.69 M | 1.69 M | 5.71 M | 5.71 M | 5.71 M | 5.71 M | 7.57 M | 7.57 M | 7.57 M | 7.57 M | 5.87 M | 5.87 M | 5.87 M | 5.87 M | 8.39 M | 8.39 M | 8.39 M | 8.39 M | 2.4 M | 2.4 M | 2.4 M | 2.4 M |
Book Value |
1.12 M | 1.78 M | 1.5 M | 1.8 M | 2.43 M | 2.6 M | 2.82 M | 2.99 M | - | 3.52 M | 3.85 M | 4.33 M | 4.82 M | 4.8 M | 5.38 M | - | 3.16 M | 3.78 M | 4.35 M | 4.33 M | 4.86 M | 5.33 M | 5.33 M | 5.33 M | 5.33 M | 7.06 M | 7.06 M | 7.06 M | 7.06 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 2.88 M | 2.88 M | 2.88 M | 2.88 M | 5.27 M | 5.27 M | 5.27 M | 5.27 M | 9.54 M | 9.54 M | 9.54 M | 9.54 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 12 M | 12 M | 12 M | 12 M | 14.4 M | 14.4 M | 14.4 M | 14.4 M | 4.42 M | 4.42 M | 4.42 M | 4.42 M |
Total Shareholders Equity |
1.12 M | 1.78 M | 1.5 M | 1.8 M | 2.43 M | 2.6 M | 2.82 M | 2.99 M | 3.08 M | 3.52 M | 3.85 M | 4.33 M | 4.82 M | 4.8 M | 5.38 M | 2.41 M | 3.16 M | 3.78 M | 4.35 M | 4.33 M | 4.86 M | 5.33 M | 5.33 M | 5.33 M | 5.33 M | 7.06 M | 7.06 M | 7.06 M | 7.06 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 2.57 M | 2.57 M | 2.57 M | 2.57 M | 4.9 M | 4.9 M | 4.9 M | 4.9 M | 9.08 M | 9.08 M | 9.08 M | 9.08 M | 12.1 M | 12.1 M | 12.1 M | 12.1 M | 11.9 M | 11.9 M | 11.9 M | 11.9 M | 14.2 M | 14.2 M | 14.2 M | 14.2 M | 4.11 M | 4.11 M | 4.11 M | 4.11 M |
Quarterly performance
Select metrics to display
All numbers in USD currency
Balance Sheet is a fundamental financial report of Research Frontiers Incorporated, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Electronic components
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
CPS Technologies Corporation
CPSH
|
$ 3.51 | 0.72 % | $ 53.7 M |  USA |
 |
CTS Corporation
CTS
|
$ 56.23 | 1.53 % | $ 1.66 B | USA |
 |
Data I/O Corporation
DAIO
|
$ 2.59 | 0.39 % | $ 24.2 M | USA |
 |
Fabrinet
FN
|
$ 356.06 | 0.16 % | $ 12.8 B |  Cayman-islands |
 |
Atotech Limited
ATC
|
- | 0.04 % | $ 4.41 B |  Germany |
 |
Benchmark Electronics
BHE
|
$ 71.25 | 1.12 % | $ 2.56 B | USA |
 |
Littelfuse
LFUS
|
$ 389.65 | 1.57 % | $ 9.67 B | USA |
 |
Amphenol Corporation
APH
|
$ 79.2 | -0.18 % | $ 96.5 B | USA |
 |
Methode Electronics
MEI
|
$ 14.56 | 2.86 % | $ 517 M | USA |
 |
Celestica
CLS
|
$ 304.61 | 1.61 % | $ 35.1 B |  Canada |
 |
OSI Systems
OSIS
|
$ 196.93 | 1.06 % | $ 3.27 B | USA |
 |
Plexus Corp.
PLXS
|
$ 238.71 | 0.96 % | $ 6.45 B | USA |
 |
Rogers Corporation
ROG
|
$ 140.51 | 2.7 % | $ 2.56 B | USA |
 |
Flex Ltd.
FLEX
|
$ 86.25 | -1.42 % | $ 32 B |  Singapore |
 |
TE Connectivity Ltd.
TEL
|
$ 214.09 | 0.2 % | $ 63.6 B |  Schweiz |
 |
Vicor Corporation
VICR
|
$ 213.42 | 4.55 % | $ 9.61 B | USA |
 |
Bel Fuse Class A
BELFA
|
$ 176.83 | 2.99 % | $ 3.07 B | USA |
 |
Bel Fuse Class B
BELFB
|
$ 220.55 | 3.84 % | $ 3.07 B | USA |
 |
LightPath Technologies
LPTH
|
$ 7.55 | 0.13 % | $ 309 M | USA |
 |
LSI Industries
LYTS
|
$ 19.68 | 1.65 % | $ 647 M | USA |
 |
Neonode
NEON
|
$ 0.78 | -1.34 % | $ 13.1 M |  Schweden |
 |
Nortech Systems Incorporated
NSYS
|
$ 10.32 | 2.38 % | $ 28.7 M | USA |
 |
Richardson Electronics, Ltd.
RELL
|
$ 19.71 | 3.74 % | $ 293 M | USA |
 |
Sanmina Corporation
SANM
|
$ 172.07 | 1.36 % | $ 9.28 B | USA |
 |
Corning Incorporated
GLW
|
$ 134.92 | 2.03 % | $ 115 B | USA |
 |
Jabil
JBL
|
$ 280.99 | 1.37 % | $ 30.8 B | USA |
 |
Kopin Corporation
KOPN
|
$ 3.54 | 3.21 % | $ 606 M | USA |
 |
VIA optronics AG
VIAO
|
- | -4.25 % | $ 997 K | - |
 |
SMTC Corporation
SMTX
|
- | - | $ 172 M | Canada |
 |
IEC Electronics Corp.
IEC
|
- | - | $ 164 M | USA |
 |
Allied Motion Technologies
AMOT
|
- | 2.07 % | $ 526 M | USA |
 |
SigmaTron International
SGMA
|
- | - | $ 18.4 M | USA |
 |
The LGL Group
LGL
|
$ 6.81 | 2.7 % | $ 37.8 M | USA |
 |
TTM Technologies
TTMI
|
$ 102.15 | 6.95 % | $ 10.5 B | USA |